Amyloid β peptide of Alzheimer's disease downregulates bcl-2 and upregulates bax expression in human neurons

Journal of Neuroscience

Volumn 16, Issue 23, 1996, Pages 7533-7539

  Paradis, Eric ^a   Douillard, Hélène ^a   Koutroumanis, Maria ^a   Goodyer, Cynthia ^b   LeBlanc, Andréa ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

Alzheimer's disease; amyloid peptide; apoptosis; bax; bcl 2; human neuron primary cultures

Indexed keywords

AMYLOID BETA PROTEIN; PROTEIN BAX; PROTEIN BCL 2;

ALZHEIMER DISEASE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; FETUS; GENE EXPRESSION; HUMAN; HUMAN CELL; NERVE CELL; NERVE CELL DEGENERATION; PRIORITY JOURNAL;

EID: 0029860523     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.16-23-07533.1996     Document Type: Article

References (54)

1. Anderson AJ, Cummings BJ, Cotman CW (1994) Increased immunoreactivity of jun- and Cos-related proteins in Alzheimer's disease: association with pathology. Exp Neurol 125:286-295.
2. Anderson AJ, Su JH, Cotman CW (1996) DNA damage and apoptosis in Alzheimer's disease: colocalization with c-jun immunoreactivity, relationship to brain area, and effect of postmortem delay. J Neurosci 16:1710-1719.
3. Bafy G, Miyashita J, Williamson J, Reed J (1993) Apoptosis induced by withdrawal of interleukin-3 (IL-3)-dependent hemapoeitic cell line is associated with repartitioning of intracellular calcium and is blocked by enforced Bcl-2 oncoprotein production. J Biol Chem 268:6511-6519.
4. Batistatou A, Merry DE, Korsmeyer SJ, Greene LA (1993) Bcl-2 affects survival but not neuronal differentiation of PC12 cells. J Neurosci 13:4422-4428.
5. Behl C, Davis J, Lesley R, Schubert D (1994) Hydrogen peroxide mediates amyloid β protein toxicity. Cell 77:817-827.
6. Busciglio J, Lorenzo A, Yeh J, Yankner BA (1995) β-amyloid fibrils induce tau phosphorylation and loss of microtubule binding. Neuron 14:879-888.
7. Cai X, Golde T, Younkin S (1993) Release of excess amyloid β protein from a mutant amyloid β protein precursor. Science 259:514-516.
8. Citron M, Oltersdorf T, Haass C, McConlogue L, Hung A, Seubert P, Vigo-Pelfrey C, Lieherburg I, Selkoe D (1992) Mutation of the β-amyloid precursor protein in familial Alzheimer's disease increases β-amyloid protein production. Nature 360:672-679.
9. Citron M, Vigo-Pelfrey C, Teplow D, Miller C, Schenk D, Johnston J, Winblad B, Venizelos N, Lannfelt L, Selkoe D (1994) Excessive production of amyloid β-protein by peripheral cells of symptomatic and presymptomatic patients carrying the Swedish familial Alzheimer disease mutation. Proc Natl Acad Sci USA 91:11993-11997.
10. Coyle JT, Puttfarcken P (1993) Oxidative stress, glutamate, and neurodegenerative disorders. Science 262:689-695.
11. Dubois-Dauphin M, Frankowski H, Tsujimoto Y, Huarte J (1994) Neonatal motorneuron overexpressing the bcl-2 protooncogene in transgenic mice are protected from axotomy-induced cell death. Proc Natl Acad Sci USA 91:3309-3313.
12. Forloni G, Chiesa R, Smiroldo S, Verga L, Salmona M, Tagliavini F, Angeretti N (1993) Apoptosis mediated neurotoxicity induced by chronic application of β amyloid fragment 25-35. NeuroReport 4:523-526.
13. Games D, Adams D, Alessandrini R, Barbour R, Berthelette P, Blackwell C, Carr T, Clemens J, Donaldson T, Gillespie F, Guido T, Hagopian S, Johnson-Wood K, Khan K, Lee M, Leibowitz P, Lieberburg I, Little S, Masliah E, McConlogue L, Montoya-Zavala M, Mucke L, Paganini L, Penniman E, Power M, Schenk D, Seubert P, Snyder B, Soriano F, Tan H, Vitale J, Wadsworth S, Wolozin B, Zhao J (1995) Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid protein. Nature 373:523-527.
14. Garcia I, Martinou I, Tsujimoto Y, Martinou J (1992) Prevention of programmed cell death of sympathetic neurons by the bcl-2 protooncogene. Science 258:302-304.
15. Haass C, Hung A, Selkoe D, Teplow D (1994) Mutations associated with a locus for familial Alzheimer's disease result in alternative processing of amyloid β-protein precursor. J Biol Chem 269:17741-17748.
16. Higgins LS, Rodems JM, Catalano R, Cordell B (1995) Early Alzheimer disease-like histopathology increases in frequency with age in mice transgenic for β-APP751. Proc Natl Acad Sci USA 92:4402-4406.
17. Hockenbery DM, Oltvai ZN, Yin X-M, Milliman C, Korsmeyer SJ (1993) Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 75:241-251.
18. Hsiao K, Borcheldt D, Olson K, Johannsdottir R, Kitt C, Yunis W, Xu S, Eckman C, Younkin S, Price D, Iadecola C, Clark B, Carlson G (1995) Age-related CNS disorder and early death in transgenic FVB/N mice overexpressing Alzheimer amyloid precursor protein. Neuron 15:1203-1208.
19. Iwatsubo T, Okada A, Suzuki N, Mizusawa H, Nukina N, Ihara Y (1994) Visualization of Aβ42(43) and Aβ40 in senile plaques with end-specific Aβ monoclonals: evidence that an initially deposited species is Aβ42(43). Neuron 13:45-53.
20. Jacobson MD, Raff M (1995) Programmed cell death and bcl-2 protection in very low oxygen. Nature 374:814-816.
21. Jarrett J, Berger E, Lansbury P (1993) The carboxy terminus of the β-amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease. Biochemistry 32:4693-4697.
22. Kane DJ, Sarafian TA, Anton R, Hahn H, Gralla E, Valentine JS, Ord T, Bredesen DE (1993) Bcl-2 inhibition of neural cell death: decreased generation of reactive oxygen species. Science 262:1274-1277.
23. Kuo YM, Emmerling MR, Vigo-Pelfrey C, Kasunic TC, Kirkpatrick JB, Murdoch GH, Ball MJ, Roher AE (1996) Water-soluble Aβ (N-40, N-42) oligomers in normal and Alzheimer disease brains. J Biol Chem 271:4077-4081.
24. LaFerla FM, Tinkle BT, Bieberich CJ, Haudenschild CC, Jay G (1995) The Alzheimer's Aβ peptide induces neurodegeneration and apoptotic cell death in transgenic mice. Nature Genet 9:21-30.
25. Lassmann H, Bancher C, Breitschopf H, Wegiel J, Bobinski M, Jellinger K, Wisniewski H (1995) Cell death in Alzheimer's disease evaluated by DNA fragmentation in situ. Acta Neuropathol 89:35-41.
26. LeBlanc AC (1995) Increased production of 4 kDa amyloid β peptide in serum-deprived human primary neuron cultures: possible involvement of apoptosis. J Neurosci 15:7837-7846.
27. Levy-Lahad E, Wasco W, Poorkej P, Romano DM, Oshima J, Pettingell WH, Yu C, Jondro P, Schmidt S, Wang K, Crowley A, Fu Y, Guenette S, Galas D, Nemens E, Wijsman E, Bird T, Schellenberg G, Tanzi R (1995) Candidate gene for the chromosome 1 familial Alzheimer's Disease locus. Science 269:973-977.
28. Loo D, Copani A, Pike CJ, Whittemore E, Walencewicz AJ, Cotman CW (1993) Apoptosis is induced by β-amyloid in cultured central nervous system neurons. Proc Natl Acad Sci USA 90:7951-7955.
29. Mah SP, Zhong LT, Liu Y, Roghani A, Edwards RH, Bredesen DE (1993) The protooncogene bcl-2 inhibits apoptosis in PC12 cells. J Neurochem 60:1183-1186.
30. Martinou J-C, Dubois-Dauphin M, Staple JK, Rodriguez I, Frankowski H, Missotten M, Albertini P, Talabot D, Catsicas S, Pietra C, Huarte J (1994) Overexpression of bcl-2 in transgenic mice protects neurons from naturally occurring cell death and experimental ischemia. Neuron 13:1017-1030.
31. Mattson MP, Cheng B, Davis D, Bryant K, Lieberburg I, Rydel RE (1992) β-amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity. J Neurosci 12:376-389.
32. Meda L, Cassatella M, Szendrei G, Otvos L, Baron P, Villalba M, Ferrari D, Rossi F (1995) Activation of microglial cells by β-amyloid protein and interferon-gamma. Nature 374:647-650.
33. Mullaart E, Boerrigter M, Ravid R, Swabb D, Vijg J (1990) Increased levels of DNA breaks in cerebral cortex of Alzheimer's disease patients. Neurobiol Aging 11:169-173.
34. Munsick RA (1984) Human foetal extremity lengths in the interval from 9 to 21 menstrual weeks of pregnancy. Am J Obstet Gynecol 149:883-887.
35. Nakamura T, Shoji M, Harigaya Y, Watanabe M, Hosoda K, Cheung T, Shatter L, Golde T, Younkin L, Younkin S, Hirai S (1994) Amyloid β protein levels in cerebrovascular fluid are elevated in early-onset Alzheimer's disease. Ann Neurol 36:903-911.
36. Pike CJ, Burdick D, Walencewicz AJ, Glabe CG, Cotman CW (1993) Neurodegeneration induced by β-amyloid peptides in vitro: the role of peptide assembly state. J Neurosci 13:1676-1687.
37. Querfurt HW, Wisjsman EM, St. George Hyslop P, Selkoe D (1995) βAPP mRNA transcription is increased in cultured fibroblasts from the familial Alzheimer's disease-1 family. Mol Brain Res 28:319-337.
38. Rabizadeh A, Bitler CM, Butcher LL, Bredesen DE (1994) Expression of the low-affinity nerve growth factor receptor enhances β-amyloid peptide toxicity. Proc Natl Acad Sci USA 91:10703-10706.
39. Satou T, Cummings BJ, Cotman CW (1995) Immunoreactivity for bcl-2 protein within neurons in the Alzheimer's disease brain increases with disease severity. Brain Res 697:35-43.
40. Shearman M, Ragan C, Iversen L (1994) Inhibition of PC12 cell redox activity is a specific, early indicator of the mechanism of β-amyloid-mediated cell death. Proc Natl Acad Sci USA 91:1470-1474.
41. Sherrington R, Rogaev EJ, Liang Y, Rogaeva EA, Levesque G, Ikeda M, Chi H, Lin C, Li G, Holman K, Tauda T, Mar L, Foncin J-F, Bruni AC, Montreal MP, Sorbi S, Rainero I, Pinessi L, Nee L, Chumakov I, Pollen D, Brookes A, Sanseau P, Pollinsky RJ, Wasco W, Da Silva HAR, Haines JL, Pericak-Vance MA, Tanzi RE, Roses AD, Fraser P, Rommens JM, St. George-Hyslop PH (1995) Cloning of a gene bearing mis-sense mutations in early-onset familial Alzheimer's disease. Nature 375:754-760.
42. Sheuner D, Eckman C, Jensen M, Song X, Citron M, Suzuki N, Bird T, Hardy J, Hutton M, Kukull W, Larson E, Levy-Lahad E, Viitanen M, Peskind E, Poorkaj P, Schellenberg G, Tanzi R, Wasco W, Lannfelt L, Selkoe D, Younkin S (1996) Secreted amyloid β-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease. Nat Med 2:864-870.
43. Shimizu S, Eguchi Y, Kosaka H, Kamlike W, Matsuda H, Tsujimoto Y (1995) Prevention of hypoxia-induced cell death by bcl-2 and bcl-xL. Nature 374:811-813.
44. Su J, Anderson A, Cummings B, Cotman C (1994) Immunohistochemical evidence for apoptosis in Alzheimer's disease. NeuroReport 5:2529-2533.
45. Suzuki N, Cheung T, Cai D, Odaka A, Laslo O, Eckman C, Golde T, Younkin S (1994) An increased percentage of long amyloid β protein secreted by familial amyloid β protein precursor (βAPP117) mutants. Science 264:1336-1340.
46. Tanzi R, Gusella J, Watkins P, Bruns G, St. George-Hyslop P, Van Keuren M, Patterson D, Pagan S, Kurnit D, Neve R (1987) Amyloid β protein gene: cDNA, mRNA distribution, and genetic linkage near the Alzheimer locus. Science 235:880-884.
47. Teller JK, Russo C, DeBusk LM, Angelini G, Zaccheo D, Dagna-Bricarelli F, Scartezinni P, Bertolini S, Mann DMA, Tabaton M, Gambetti P (1996) Presence of soluble β-amyloid peptide precedes amyloid plaque formation in Down's syndrome. Nat Med 2:93-95.
48. Thomas T, Thomas G, McLendon C, Sutton T, Mullan M (1996) β-amyloid-mediated vasoactivity and vascular endothelial damage. Nature 380:168-171.
49. Van Gool WA, Schenk DB, Bolhuis PA (1994) Concentrations of amyloid-β peptide in cerebrospinal fluid increase with age in patients free from neurodegenerative disease. Neurosci Lett 172:122-124.
50. Veis DJ, Sorenson CM, Shutter JR, Korsmeyer SJ (1993) Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidne'ys, and hypopigmented hair. Cell 75:229-240.
51. Watt JA, Pike CJ, Walencewicz AJ, Cotman CW (1994) Ultrastructural analysis of β-amyloid-induced apoptosis in cultured hippocampal neurons. Brain Res 661:147-156.
52. Wisniewski K, Wisniewski H, Wen G (1985) Occurrence of neuropathological changes and dementia of Alzheimer's disease in Down's syndrome. Ann Neurol 17:278.
53. Yamatsuji T, Okamoto T, Takeda S, Murayama Y, Tanaka N, Nishimoto I (1996) Expression of V642 APP mutant causes cellular apoptosis as Alzheimer trait-linked phenotype. EMBO J 15:498-509.
54. Yankner BA, Duffy LK, Kirschner DA (1990) Neurotrophic and neurotoxic effects of amyloid β protein: reversal by tachykinin neuropeptides. Science 250:279-286.